10月16日，福瑞股份跌0.42%，成交额4.02亿元。两融数据显示，当日福瑞股份获融资买入额4317.00万 元，融资偿还4345.51万元，融资净买入-28.51万元。截至10月16日，福瑞股份融资融券余额合计11.99 亿元。 机构持仓方面，截止2025年6月30日，福瑞股份十大流通股东中，华宝中证医疗ETF（512170）位居第 二大流通股东，持股871.28万股，相比上期增加94.78万股。睿远成长价值混合A（007119）位居第五大 流通股东，持股556.66万股，相比上期减少128.30万股。南方医药保健灵活配置混合A（000452）位居 第十大流通股东，持股388.99万股，相比上期增加15.90万股。 责任编辑：小浪快报 资料显示，内蒙古福瑞医疗科技股份有限公司位于北京市朝阳区新源里16号琨莎中心2座7层，成立日期 2001年12月26日，上市日期2010年1月20日，公司主营业务涉及从事肝病领域的药品生产与销售、仪器 研发与销售、医疗服务业务。主营业务收入构成为：设备及技术67.57%，药品27.47%，医疗服务 4.30%，其他0.65%。 截至9月20日，福瑞股份股东户数2.59万，较 ...

Group 1 - The core viewpoint of the news highlights the recent trading performance and financial metrics of Furuya Co., indicating a significant increase in financing activities and stockholder engagement [1][2]. - On September 17, Furuya Co. saw a stock price increase of 2.36% with a trading volume of 1.473 billion yuan, and a net financing purchase of 64.34 million yuan [1]. - As of September 17, the total financing and securities balance for Furuya Co. reached 1.197 billion yuan, which is at a high level compared to the past year [1]. Group 2 - As of September 10, the number of shareholders for Furuya Co. increased by 6.75% to 27,400, while the average circulating shares per person decreased by 6.33% to 8,532 shares [2]. - For the first half of 2025, Furuya Co. reported a revenue of 713 million yuan, reflecting a year-on-year growth of 11.02%, while the net profit attributable to shareholders decreased by 31.09% to 51.934 million yuan [2]. - Furuya Co. has distributed a total of 246 million yuan in dividends since its A-share listing, with 52.6106 million yuan distributed over the last three years [3].